Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 24230979)

1.

A meta-analysis of randomized head-to-head trials for effects of rosuvastatin versus atorvastatin on apolipoprotein profiles.

Takagi H, Umemoto T; ALICE (All-Literature Investigation of Cardiovascular Evidence) Group.

Am J Cardiol. 2014 Jan 15;113(2):292-301. doi: 10.1016/j.amjcard.2013.08.043. Epub 2013 Oct 3. Review.

PMID:
24230979
2.

Response to Comment on Stegman et al. High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: insights from SATURN. Diabetes Care 2014;37:3114-3120.

Stegman B, Puri R, Shao M, Nicholls SJ.

Diabetes Care. 2015 Feb;38(2):e28-9. doi: 10.2337/dc14-2552. No abstract available.

PMID:
25614701
3.
4.

Effects of atorvastatin and rosuvastatin on renal function in patients with type 2 diabetes mellitus.

Lai CL, Chou HW, Chan KA, Lai MS.

Am J Cardiol. 2015 Mar 1;115(5):619-24. doi: 10.1016/j.amjcard.2014.12.009. Epub 2014 Dec 18.

PMID:
25591893
5.

A network meta-analysis on randomized trials focusing on the preventive effect of statins on contrast-induced nephropathy.

Peruzzi M, De Luca L, Thomsen HS, Romagnoli E, D'Ascenzo F, Mancone M, Sardella G, Lucisano L, Abbate A, Frati G, Biondi-Zoccai G.

Biomed Res Int. 2014;2014:213239. doi: 10.1155/2014/213239. Epub 2014 Sep 7.

6.

Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin.

Puri R, Nissen SE, Shao M, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Libby P, Raichlen JS, Uno K, Kataoka Y, Nicholls SJ.

Arterioscler Thromb Vasc Biol. 2014 Nov;34(11):2465-72. doi: 10.1161/ATVBAHA.114.303932. Epub 2014 Sep 11.

PMID:
25212234
7.

[Impact on the carotid intima-medial thickness and safety of rosuvastatin in Chinese patients with carotid atherosclerosis: a meta-analysis].

Feng X, Zhang J, Liu M, Li X.

Zhonghua Xin Xue Guan Bing Za Zhi. 2014 Mar;42(3):247-53. Chinese.

PMID:
24831484
8.

Statins combined with exercise are associated with the increased renal function mediated by high-molecular-weight adiponectin in coronary artery disease patients.

Toyama K, Sugiyama S, Oka H, Iwasaki Y, Sumida H, Tanaka T, Tayama S, Jinnouchi H, Ogawa H.

J Cardiol. 2014 Aug;64(2):91-7. doi: 10.1016/j.jjcc.2013.11.018. Epub 2014 Jan 20.

PMID:
24457019
9.

Beyond greyscale IVUS assessment of progression/regression: it should be simple, but it's not.

Mintz GS.

Eur Heart J Cardiovasc Imaging. 2014 Apr;15(4):378-9. doi: 10.1093/ehjci/jet291. Epub 2014 Jan 20. No abstract available.

PMID:
24448226
10.

Pharmacodynamic effects of atorvastatin versus rosuvastatin in coronary artery disease patients with normal platelet reactivity while on dual antiplatelet therapy--the PEARL randomized cross-over study.

Pelliccia F, Rosano G, Marazzi G, Vitale C, Spoletini I, Franzoni F, Speziale G, Polacco M, Greco C, Gaudio C.

Eur J Pharmacol. 2014 Feb 15;725:18-22. doi: 10.1016/j.ejphar.2014.01.006. Epub 2014 Jan 17.

PMID:
24444439
11.

Comparision of effects of rosuvastatin versus atorvastatin treatment on plasma levels of asymmetric dimethylarginine in patients with hyperlipidemia having coronary artery disease.

Kurtoglu E, Balta S, Sincer I, Altas Y, Atas H, Yilmaz M, Korkmaz H, Erdem K, Akturk E, Demirkol S, Can C.

Angiology. 2014 Oct;65(9):788-93. doi: 10.1177/0003319713507333. Epub 2013 Oct 24.

PMID:
24163120
12.

Efficacy and safety of ezetimibe added to atorvastatin versus atorvastatin uptitration or switching to rosuvastatin in patients with primary hypercholesterolemia.

Bays HE, Averna M, Majul C, Muller-Wieland D, De Pellegrin A, Giezek H, Lee R, Lowe RS, Brudi P, Triscari J, Farnier M.

Am J Cardiol. 2013 Dec 15;112(12):1885-95. doi: 10.1016/j.amjcard.2013.08.031. Epub 2013 Sep 21.

PMID:
24063830
13.

Effects of adding statins before surgery on mortality and major morbidity: a meta-analysis.

Guay J, Ochroch EA.

J Cardiothorac Vasc Anesth. 2014 Apr;28(2):255-66. doi: 10.1053/j.jvca.2013.03.007. Epub 2013 Sep 5. Review.

PMID:
24011872
14.

NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin.

Satoh M, Tabuchi T, Itoh T, Nakamura M.

Clin Sci (Lond). 2014 Feb;126(3):233-41. doi: 10.1042/CS20130043.

PMID:
23944632
15.

Clinical and pharmacogenetic predictors of circulating atorvastatin and rosuvastatin concentrations in routine clinical care.

DeGorter MK, Tirona RG, Schwarz UI, Choi YH, Dresser GK, Suskin N, Myers K, Zou G, Iwuchukwu O, Wei WQ, Wilke RA, Hegele RA, Kim RB.

Circ Cardiovasc Genet. 2013 Aug;6(4):400-8. doi: 10.1161/CIRCGENETICS.113.000099. Epub 2013 Jul 22.

16.

Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery.

Sanders RD, Nicholson A, Lewis SR, Smith AF, Alderson P.

Cochrane Database Syst Rev. 2013 Jul 3;7:CD009971. doi: 10.1002/14651858.CD009971.pub2. Review.

PMID:
23824754
17.

Effects of rosuvastatin versus atorvastatin on small dense low-density lipoprotein: a meta-analysis of randomized trials.

Takagi H, Niwa M, Mizuno Y, Yamamoto H, Goto SN, Umemoto T.

Heart Vessels. 2014 May;29(3):287-99. doi: 10.1007/s00380-013-0358-6. Epub 2013 May 5. Review.

PMID:
23644555
18.

Factors underlying regression of coronary atheroma with potent statin therapy.

Puri R, Nissen SE, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Libby P, Raichlen JS, St John J, Wolski K, Uno K, Kataoka Y, Nicholls SJ.

Eur Heart J. 2013 Jun;34(24):1818-25. doi: 10.1093/eurheartj/eht084. Epub 2013 May 3.

19.

Statin wars: the heavyweight match--atorvastatin versus rosuvastatin for the treatment of atherosclerosis, heart failure, and chronic kidney disease.

DiNicolantonio JJ, Lavie CJ, Serebruany VL, O'Keefe JH.

Postgrad Med. 2013 Jan;125(1):7-16. doi: 10.3810/pgm.2013.01.2620. Review.

PMID:
23391667
20.

The efficacy and safety of ezetimibe/simvastatin combination compared with intensified lipid-lowering treatment strategies in diabetic subjects with and without metabolic syndrome.

Jimenez JG, Rosen JB, Pirags V, Massaad R, Hanson ME, Brudi P, Triscari J.

Diabetes Obes Metab. 2013 Jun;15(6):513-22. doi: 10.1111/dom.12059. Epub 2013 Jan 25.

PMID:
23279632
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk